tiprankstipranks
Bayer AG (BAYRY)
OTHER OTC:BAYRY
US Market
BAYRY
Bayer
RESEARCH TOOLSreports

Bayer (BAYRY) Stock News & Sentiment

2,096 Followers
Bayer Targets India Hemophilia Market With New Real World Safety Study
Premium
Company Announcements
Bayer Targets India Hemophilia Market With New Real World Safety Study
4d ago
BAYRY
Bayer’s ARDS ICU Study Shines Light on Long-Term Risks and Costs
Premium
Company Announcements
Bayer’s ARDS ICU Study Shines Light on Long-Term Risks and Costs
10d ago
BAYRY
Bayer’s Double-DARE Prostate Cancer Study Builds Real-World Case for Nubeqa
Premium
Company Announcements
Bayer’s Double-DARE Prostate Cancer Study Builds Real-World Case for Nubeqa
11d ago
BAYRY
Bayer’s ACO-REAL Study: Real-World Data on Acoramidis Could Shape ATTR-CM Market Prospects
Premium
Company Announcements
Bayer’s ACO-REAL Study: Real-World Data on Acoramidis Could Shape ATTR-CM Market Prospects
12d ago
BAYRY
Bayer Targets Earlier Prostate Cancer Use for Darolutamide With New China Phase 2 Trial
Premium
Company Announcements
Bayer Targets Earlier Prostate Cancer Use for Darolutamide With New China Phase 2 Trial
1M ago
BAYRY
Bayer Earnings Call: Solid Execution, Heavy Legal Overhang
Premium
Company Announcements
Bayer Earnings Call: Solid Execution, Heavy Legal Overhang
1M ago
Bayer’s Real-World Colorectal Cancer Data Could Quietly Support BAYRY
Premium
Company Announcements
Bayer’s Real-World Colorectal Cancer Data Could Quietly Support BAYRY
1M ago
BAYRY
More BAYRY News >

BAYRY News on the Web

Bayer upgraded to Hold from Sell at DZ Bank
TipRanks News
Bullish
DZ BANK AG upgrades Bayer (0P6S) to a Hold
TipRanks News
Neutral
Bayer Targets India Hemophilia Market With New Real World Safety Study
TipRanks News
Neutral
Regeneron Wins FDA Nod for Extended Eylea HD Dosing Interval
Zacks
Neutral
Bayer Advances AB-1002 Study, Highlights Pharma Growth Strategy
Zacks
Bullish
Bayer’s ARDS ICU Study Shines Light on Long-Term Risks and Costs
TipRanks News
Neutral
Kepler Capital Sticks to Their Buy Rating for Bayer (0P6S)
TipRanks News
Bullish
Bayer’s Double-DARE Prostate Cancer Study Builds Real-World Case for Nubeqa
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
BAYRY
Sector Average
Media Buzz
This Week4 articles
Weekly Average5.5 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BAYRY’s Media Buzz Sentiment?
4 articles about BAYRY were published this week. In an average week, 5.5 articles are published.
    What is BAYRY’s weekly average amount of articles?
    In an average week, 5.5 articles about BAYRY are published.
      What is BAYRY’s News Sentiment?
      100% of articles about BAYRY were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week